Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Aptar CSP Technologies launches Activ-Blister for oral slide dose drugs in EMEA

By Brian Buntz | May 12, 2022

Active Blister

[Image courtesy of Aptar CSP Technologies]

Material science specialist Aptar CSP Technologies (Auburn, Alabama) has opened a new manufacturing site in Europe that can produce its Activ-Blister technologies for oral slide dose drugs.

Three companies were involved in opening the facility, including Aptar CSP, pharma packaging equipment firm Uhlmann and Ivers-Lee, a contract manufacturer.

Uhlmann provided a blister machine validated to package oral solid dose drug products with Aptar CSP’s Activ-Blister packaging. The machine can produce up to 250 blisters per minute.

Aptar CSP notes that a contract manufacturing organization in EMEA will provide customer support for local companies.

The company plans to eventually introduce the technology to the Asian market.

“Expanding global manufacturing sites for Activ-Blister technology reflects our commitment to delivering global access to innovative active material science solutions for patients and consumers,” said Badre Hammond, VP Commercial Operations and GM APAC, Aptar CSP Technologies, in a statement.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

thermo fisher-sanofi
Thermo Fisher, Sanofi expand drug manufacturing partnership
Nelipak logo (1)
Nelipak earns certifications at Derry facility
MilliporeSigma Rockville Maryland Biosafety plant (1)
MilliporeSigma opens $317M biosafety plant in Maryland
Thermo Fisher Scientific
Thermo Fisher introduces new sustainable antibody packaging
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE